文献速递免疫规划卫生政策与健康促进

HLA II类单倍型与芬兰四个年龄组Tdap加强免疫后抗体浓度的关联

Association of HLA class II haplotypes with antibody concentrations after diphtheria-tetanus acellular pertussis booster vaccination in four age groups of Finnish participants.
PubMed 文献 · Vaccine · 2026-05-15

研究纳入芬兰7-10岁儿童、11-15岁青少年、20-34岁年轻成人及60-70岁老年人,接种Tdap3-IPV加强针后检测PT、FHA、PRN、DT、TT抗体及PT中和抗体。经FDR校正后,(DR7)-DQA1*02:01-DQB1*02与较低抗PT IgG相关,(DR15)-DQB1*06:02与时间依赖性抗FHA IgG应答相关且加强前浓度较高。提示特定HLA单倍型可能调节aP疫苗免疫应答。

要点

  • (DR7)-DQA1*02:01-DQB1*02携带者加强后抗PT IgG较低。
  • (DR15)-DQB1*06:02与时间依赖性抗FHA IgG应答相关且加强前浓度较高。
  • HLA II类单倍型可能影响aP加强免疫的抗体应答。

核心结论

  • 特定HLA II类单倍型可能调节对aP疫苗的免疫应答。
  • 需进一步研究阐明HLA II类单倍型如何影响不同人群的aP疫苗应答。

研究设计与样本

  • 健康芬兰儿童7-10岁n=37、青少年11-15岁n=37、年轻成人20-34岁n=25、老年人60-70岁n=25接种Tdap3-IPV加强针。
  • 加强前、加强后1个月和1年检测PT、FHA、PRN、DT、TT抗体及PT中和抗体。
  • 采用PCR及等位基因特异性探针杂交进行HLA-DR/DQ分型,并与芬兰儿童糖尿病登记库对照队列比较单倍型频率。

主要发现

  • 队列HLA DR-DQ单倍型频率与对照组无差异。
  • 经FDR校正后,(DR7)-DQA1*02:01-DQB1*02与较低抗PT IgG相关。
  • 经FDR校正后,(DR15)-DQB1*06:02与时间依赖性抗FHA IgG应答相关且加强前浓度较高。
  • 名义上,(DR8)-DQB1*04和(DR7)-DQA1*02:01-DQB1*02携带者PTNA较低。
  • 名义上,(DR13)-DQB1*06:03携带者所有时间点抗DT consistently较低。

临床怎么用

  • 提示HLA分型可能有助于识别aP加强免疫抗体应答较弱的个体。
  • 对HLA易感单倍型携带者加强免疫后抗体水平可能较低,需关注其保护效果。

局限性

  • 样本量较小,各年龄组n=25至37。
  • 部分关联仅名义显著,未通过FDR校正。
  • 对照队列来自芬兰儿童糖尿病登记库父母单倍型,非完全匹配对照。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite widespread use of whole-cell (wP) and acellular (aP) pertussis vaccines, outbreaks persist in many countries. Polymorphisms in HLA class II molecules, which present antigens to CD4+ T cells, may play a vital role in vaccine responses. Emerging evidence suggests that HLA-DR/DQ variants can significantly influence wP vaccine responses. This study investigated the possible association of HLA class II haplotypes with antibody concentrations after aP booster vaccination. MATERIALS AND METHODS: Healthy Finnish children (7-10y, n = 37), adolescents (11-15y, n = 37), young adults (20-34y, n = 25), and older adults (60-70y, n = 25) received a Tdap3-IPV booster. Serum antibodies against pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (PRN), diphtheria toxoid (DT), and tetanus toxoid (TT), as well as PT-neutralizing antibodies (PTNA), were measured before, one month, and one year after the booster. Participants were HLA-typed with a stepwise HLA-DR/DQ screening system using PCR followed by allele-specific probe hybridization. The frequency of HLA haplotypes was compared to the control cohort from the Finnish Pediatric Diabetes Register, which was constructed from parental haplotypes not passed down to diabetic children. RESULTS: The HLA DR-DQ haplotype frequencies in our cohort did not differ from the control group. Two associations survived FDR correction: (DR7)-DQA1*02:01-DQB1*02 with lower anti-PT IgG and (DR15)-DQB1*06:02 with a time-dependent anti-FHA IgG response with higher pre-booster concentrations. Nominally, (DR8)-DQB1*04 and (DR7)-DQA1*02:01-DQB1*02 carriers had lower PTNA; (DR9)-DQA1*03-DQB1*03:03, (DR15)-DQB1*06:02, and DRB1*04:01-DQA1*03-DQB1*03:02 carriers had higher anti-PT and anti-Prn concentrations; and (DR13)-DQB1*06:03 carriers had consistently lower anti-DT across all timepoints. CONCLUSIONS: The present study highlights a potential role of certain HLA haplotypes in modulating immune responses to aP vaccination. These findings emphasize the importance of further research to clarify how HLA class II haplotypes influence aP vaccine responses in various populations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Anabe D, Ilonen J, Barkoff AM, et al. Association of HLA class II haplotypes with antibody concentrations after diphtheria-tetanus acellular pertussis booster vaccination in four age groups of Finnish participants. Vaccine. 2026. PMID: 42134131. doi:10.1016/j.vaccine.2026.128697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。